Register your interest for information and updates

At BOYDSense we believe in the potential of breath analysis to revolutionise health monitoring and management.
Sign up to hear more about our ongoing device, technology and platform development including our latest clinical trials and investment rounds.

BOYDSense believe in the importance of collaboration across the healthcare spectrum, from patients, health care professionals and patient advocacy groups, to insurance providers, supporters and investors.

The potential of breath analysis is growing – for diabetes and beyond

Our first application will be in diabetes, but our future development pipeline targets opportunities to risk stratify, detect, monitor and manage disease and chronic conditions across the healthcare spectrum.

Non-invasive sampling and analysis of exhaled breath offers opportunities to revolutionize healthcare in metabolic health, respiratory, oncology, neurodegenerative, bacterial infection and beyond.

Data source: BOYDSense data on file

Products currently under development.

Our ongoing device development, and latest clinical investigations continue to move our technology and devices toward market launch. To be kept up to date please sign up to our mailing list.

Backed by Leading Investors & Partners